Volume 84, Issue 5, Pages (November 2013)

Slides:



Advertisements
Similar presentations
Volume 82, Issue 12, Pages (December 2012)
Advertisements

Volume 66, Issue 4, Pages (October 2004)
Volume 66, Issue 6, Pages (December 2004)
Volume 85, Issue 5, Pages (May 2014)
Mitchell H. Rosner, W. Kline Bolton  Kidney International 
No difference in bleeding risk between subcutaneous enoxaparin and heparin for thromboprophylaxis in end-stage renal disease  Kevin E. Chan, Ravi I. Thadhani,
Volume 61, Issue 6, Pages (June 2002)
Volume 83, Issue 3, Pages (March 2013)
Volume 85, Issue 3, Pages (March 2014)
Alex Castellarnau, Michael Werner, Roman Günthner, Marten Jakob 
Rajiv Agarwal, John W. Kusek, Maria K. Pappas  Kidney International 
Volume 86, Issue 6, Pages (December 2014)
Defining Resistance and Tolerance to Cancer
Prehypertension and chronic kidney disease: the ox or the plow?
Reassessment of the care of the patient with chronic kidney disease
Volume 80, Issue 1, Pages (July 2011)
Volume 73, Issue 5, Pages (March 2008)
Volume 80, Issue 2, Pages (July 2011)
Volume 82, Issue 12, Pages (December 2012)
M. Kraemer, C. Rode, V. Wizemann  Kidney International 
Disease-Specific Predictive Formulas for Energy Expenditure in the Dialysis Population  Enric Vilar, PhD, Ashwini Machado, RN, Andrew Garrett, PhD, Robert.
The progression of chronic kidney disease: A 10-year population-based study of the effects of gender and age  B.O. Eriksen, O.C. Ingebretsen  Kidney International 
Volume 92, Issue 1, Pages (July 2017)
Volume 79, Issue 12, Pages (June 2011)
Steven G. Coca, Swathi Singanamala, Chirag R. Parikh 
Volume 76, Issue 10, Pages (November 2009)
Volume 67, Issue 1, Pages (January 2005)
Comorbidity and confounding in end-stage renal disease
Volume 74, Issue 3, Pages (August 2008)
Volume 85, Issue 4, Pages (April 2014)
Bradley A. Ford, Daniel W. Coyne, Charles S. Eby, Mitchell G. Scott 
U-shaped effect of eGFR and mortality
Volume 74, Issue 9, Pages (November 2008)
Charles R. Nolan, Wajeh Y. Qunibi  Kidney International 
Volume 79, Issue 2, Pages (January 2011)
Volume 73, Issue 12, Pages (June 2008)
The C5a receptor has a key role in immune complex glomerulonephritis in complement factor H–deficient mice  Jessy J. Alexander, Lee Chaves, Anthony Chang,
Volume 76, Issue 6, Pages (September 2009)
Volume 62, Issue 5, Pages (November 2002)
Alfonso M. Cueto-Manzano, Héctor R
Volume 80, Issue 12, Pages (December 2011)
Erratum American Journal of Kidney Diseases
Methods for guideline development
Volume 68, Issue 3, Pages (September 2005)
Volume 60, Issue 3, Pages (September 2001)
Volume 76, Issue 8, Pages (October 2009)
A practical approach to the treatment of depression in patients with chronic kidney disease and end-stage renal disease  S. Susan Hedayati, Venkata Yalamanchili,
Renovascular adaptive changes in chronic hypoxic polycythemia
Volume 81, Issue 4, Pages (February 2012)
Volume 73, Issue 8, Pages (April 2008)
Volume 58, Issue 1, Pages (July 2000)
Will there be an epidemic of HIV-related chronic kidney disease in sub-Saharan Africa? Too soon to tell  Kara K. Wools-Kaloustian, Samir K. Gupta  Kidney.
Dialysis dose and gender: A different hypothesis
Erratum American Journal of Kidney Diseases
Volume 80, Issue 10, Pages (November 2011)
Volume 81, Issue 7, Pages (April 2012)
Volume 60, Issue 3, Pages (September 2001)
Bioelectric impedance vector distribution in peritoneal dialysis patients with different hydration status  Antonio Piccoli, for the Italian CAPD-BIA Study.
Volume 75, Issue 1, Pages (January 2009)
The hypothesis that abnormal BH4 metabolism impairs kidney function
Volume 87, Issue 3, Pages (March 2015)
Volume 75, Issue 9, Pages (May 2009)
The arrow of bioimpedance
Volume 66, Issue 4, Pages (October 2004)
In chronic kidney disease staging the use of the chronicity criterion affects prognosis and the rate of progression  B.O. Eriksen, O.C. Ingebretsen  Kidney.
Glomerular filtration rate via plasma iohexol disappearance: Pilot study for chronic kidney disease in children  G.J. Schwartz, S. Furth, S.R. Cole, B.
Friends, social networks, and progressive chronic kidney disease
Volume 56, Issue 1, Pages (July 1999)
Intra-individual variability in serum hepcidin precludes its use as a marker of iron status in hemodialysis patients  Bradley A. Ford, Charles S. Eby,
George D. Dickinson, Ian Parker  Biophysical Journal 
Presentation transcript:

Volume 84, Issue 5, Pages 980-988 (November 2013) Subcutaneous interstitial pressure and volume characteristics in renal impairment associated with edema  Leonard M. Ebah, Helge Wiig, Idalia Dawidowska, Charlotte O'Toole, Angela Summers, Milind Nikam, Anuradha Jayanti, Beatrice Coupes, Paul Brenchley, Sandip Mitra  Kidney International  Volume 84, Issue 5, Pages 980-988 (November 2013) DOI: 10.1038/ki.2013.208 Copyright © 2013 International Society of Nephrology Terms and Conditions

Figure 1 Comparison of and bioimpedance-derived body fluid volumes between patients and healthy volunteers. Mean (+s.d.) (a) total body water (TBW), (b) extracellular fluid volume (ECFV), and (c) interstitial fluid volume (IFV) were significantly higher in the edematous patients with renal dysfunction compared with the healthy volunteers. The mean difference (9.95l) in ECFV between patients and controls (23.96±6.69 vs. 14.01±1.55l; P=0.0008) is almost entirely accounted for by differences in IFV (mean difference 8.9l; 19.96±6.07 vs. 11.09±1.29l; P=0.0009). Kidney International 2013 84, 980-988DOI: (10.1038/ki.2013.208) Copyright © 2013 International Society of Nephrology Terms and Conditions

Figure 2 Comparison of interstitial pressure (ISP) measurements between patients with manifest edema and healthy volunteers. (a) A dot plot comparing (t-test) ISP of all patients (squares, n=17) and all healthy volunteers (circles, n=10). ISP was high (positive; 4.62±4.2mmHg) in edematous chronic kidney disease (CKD) patients and low (negative; -0.9±1.3mmHg) in healthy volunteers. (b) The patient and healthy volunteers groups are separated by gender. HV F, female healthy volunteers; HV M, male healthy volunteers; Patients F, female patients; Patients M, male patients. aA Kruskal–Wallis test showed an overall difference across the groups. bDunn’s post-hoc multiple testing adjustment shows a persistent difference of ISP between female patients and female healthy volunteers (P=0.03). The small number of male healthy volunteers precludes comparisons with this group. Kidney International 2013 84, 980-988DOI: (10.1038/ki.2013.208) Copyright © 2013 International Society of Nephrology Terms and Conditions

Figure 3 Linear regression graphs of interstitial pressure (ISP) and bioimpedance body fluid volumes. The graphs depict the linear relationships between interstitial pressure and (a) total body water (TBW), (b) segmental extracellular fluid volume (ECFV), and (c) ECFV/TBW (Bio-ratio) in the study patient group (n=15). Significant positive linear relationships are seen between ISP and TBW, and ISP and segmental ECFV, whereas the relationship between ISP and ECFV/TBW is negative (R2=0.40, r=-0.63, P=0.01). Square data points denote female patients, whereas triangles denote male patients. Kidney International 2013 84, 980-988DOI: (10.1038/ki.2013.208) Copyright © 2013 International Society of Nephrology Terms and Conditions

Figure 4 Comparison of interstitial pressure (ISP) measurements between short- and long-duration edema. Edema of up to 2 weeks of duration was categorized as ‘short duration (SD),’ whereas those of >2 weeks as ‘long duration (LD).’ The box-and-whisker plot shows that the mean (±s.d. and 95% confidence interval (CI)) ISP in patients with LD (2.13±1.56; 95% CI 0.77–7.69mmHg) is significantly lower than in SD (6.36±4.65; 95% CI 0.31–8.15mmHg; P=0.03). Kidney International 2013 84, 980-988DOI: (10.1038/ki.2013.208) Copyright © 2013 International Society of Nephrology Terms and Conditions

Figure 5 The nonlinear pressure–volume relationship in the subcutaneous interstitial compartment with varying states of hydration. The relationship between interstitial pressure (ISP) and interstitial fluid volume (IFV) in all subjects in whom both measurements were available (8 controls and 16 chronic kidney disease (CKD) patients). The second-order polynomial y=-7.9+0.8x-0.009x2 (R2=0.56, P<0.0001) depicts a change in the rate of rise of ISP with changing IFV. All controls (depicted in circles) cluster at baseline with negative pressure measurements. The patients are depicted in squares, and a separate regression line for this group (broken line, R2=0.32, P=0.03) follows a similar pattern as the curve for the whole cohort (solid line). Kidney International 2013 84, 980-988DOI: (10.1038/ki.2013.208) Copyright © 2013 International Society of Nephrology Terms and Conditions

Figure 6 Linear regression graphs of the determinants of edema refill time. (a) Total body water (TBW), (b) interstitial fluid volume (IFV), and (c) segmental extracellular fluid volume (ECFV) exhibited significant linear correlations with edema refill time (ERT; n=18). Kidney International 2013 84, 980-988DOI: (10.1038/ki.2013.208) Copyright © 2013 International Society of Nephrology Terms and Conditions